Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
06/05/2014 | US20140155813 Therapeutic muscular dystrophy drug having bubble liposome loaded with morpholino as active ingredient |
06/05/2014 | US20140155582 Novel anti-human ngf antibody |
06/05/2014 | US20140155579 Dual specificity antibodies and methods of making and using |
06/05/2014 | US20140155577 Self-assembly of therapeutic agent-peptide nanostructures |
06/05/2014 | US20140155498 Method of Manufacture of Stable Liquid Coagulation Factors |
06/05/2014 | US20140155497 Heparosan-based biomaterials and coatings and methods of production and use thereof |
06/05/2014 | US20140155496 Templated Native Silk Smectic Gels |
06/05/2014 | US20140155495 Transdermal delivery patch |
06/05/2014 | US20140155494 Tri-molecular complexes and their use in drug delivery systems |
06/05/2014 | US20140155489 Process for the production of an abuse-proofed solid dosage form |
06/05/2014 | US20140155485 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases |
06/05/2014 | US20140155457 Method of Relieving, Improving, Preventing or Treating Xerostomia |
06/05/2014 | US20140155434 Thermogelling anaesthetic compositions |
06/05/2014 | US20140155424 Naltrexone long acting formulations and methods of use |
06/05/2014 | US20140155388 Methods and compositions for self-regulated release of active pharmaceutical ingredient |
06/05/2014 | US20140155362 Bhq-conjugates, and related compounds, methods of making the same, and methods of use thereof |
06/05/2014 | US20140155360 Calcium Formate for Use as a Dietary Supplement |
06/05/2014 | US20140155348 Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same |
06/05/2014 | US20140155343 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
06/05/2014 | US20140155313 Hydrogels with covalently linked polypeptides |
06/05/2014 | US20140155267 Thermoplastic paste for repairing living tissues |
06/05/2014 | US20140154744 Compositions and Methods for Making Selenocysteine Containing Polypeptides |
06/05/2014 | US20140154335 Antimicrobial packaing |
06/05/2014 | US20140154328 Pharmaceutical Composition |
06/05/2014 | US20140154293 Intravaginal delivery system |
06/05/2014 | US20140154287 Multiple antigen presenting immunogenic composition, and methods and uses thereof |
06/05/2014 | US20140154286 Modified biotin-binding protein, fusion proteins thereof and applications |
06/05/2014 | US20140154285 Fusion proteins for use as immunogenic enhancers for inducing antigen-specific t cell responses |
06/05/2014 | US20140154273 Anthracycline-Antibody Conjugates for Cancer Therapy |
06/05/2014 | US20140154271 Methods of Treating Glucose Metabolism Disorders |
06/05/2014 | US20140154212 Crosslinked gelatin hydrogels |
06/05/2014 | US20140154203 Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using The Same |
06/05/2014 | US20140154202 Process for the identification of compounds for treating cancer |
06/05/2014 | US20140154181 Rgd-containing peptidomimetics and uses thereof |
06/05/2014 | DE102012111808A1 Bioabbaubare Kombination zur Behandlung von Erkrankungen mit erhöhtem Augeninnendruck Biodegradable combination for the treatment of diseases with elevated intraocular pressure |
06/04/2014 | EP2738158A1 Metal salen complex compound, local anesthetic, and anti-malignant tumor agent |
06/04/2014 | EP2737895A1 Microparticles with EGF, method of preparation and use |
06/04/2014 | EP2736962A1 Supramolecular capsules |
06/04/2014 | EP2736537A2 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
06/04/2014 | EP2736536A2 Templated islet cells and small islet cell clusters for diabetes treatment |
06/04/2014 | EP2736535A1 Il-12 immunoconjugate |
06/04/2014 | EP2736534A1 Combination therapy for the treatment of cd19+ b-cell malignancies symptoms comprising an anti-cd19 maytansinoid immunoconjugate and rituximab |
06/04/2014 | EP2736533A2 Selective delivery molecules and methods of use |
06/04/2014 | EP2736515A2 17-hydroxyprogesterone ester-containing oral compositions and related methods |
06/04/2014 | EP2736507A1 Basic alpha lipoic acid solution and its uses |
06/04/2014 | EP2736499A1 Sustained release tablet comprising pregabalin through two-phase release-controlling system |
06/04/2014 | EP2736491A2 Bepotastine compositions |
06/04/2014 | EP2736490A1 Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein |
06/04/2014 | EP2736485A1 Aqueous solutions of lipophilic substances, in particular medicinal solutions |
06/04/2014 | EP2736475A1 Two part formulation system for ophthalmic delivery |
06/04/2014 | CN103841994A Formulations of fluorinated stilbene suitable for pet imaging |
06/04/2014 | CN103841977A Composition containing s-adenosyl-l-methionine with excellent storage stability |
06/04/2014 | CN103834622A Recombinant PTD-Cu/Zn SOD (Protein Transduction Domain-Cu/Zn Superoxide Dismutase) protein and application thereof |
06/04/2014 | CN103834066A Low-viscosity starch glue for preparing starch capsules as well as preparation method and application of low-viscosity starch glue |
06/04/2014 | CN103834043A Preparation method of methylcellulose solution |
06/04/2014 | CN103834040A Dendrimer drug carrier G3.5 with pH and temperature supersensitivity and preparation method thereof |
06/04/2014 | CN103834036A Chitosan-polybenzyl glutamate graft copolymer and preparation method thereof |
06/04/2014 | CN103834035A Cationic laminarin and preparation method and application thereof |
06/04/2014 | CN103834003A New compound containing xalkori structure, preparation method thereof and application |
06/04/2014 | CN103834002A Preparation method and application of acid sensitive doxorubicin prodrug based on polyethylene glycol |
06/04/2014 | CN103833997A New compound with tozasertib structure as well as preparation method and application thereof |
06/04/2014 | CN103833871A Hyaluronic acid-adipodihydrazide-thymoquinone grafted polymer as well as synthesis method and application of hyaluronic acid-adipodihydrazide-thymoquinone grafted polymer |
06/04/2014 | CN103833833A Self-assembled polypeptide, preparation method and application thereof |
06/04/2014 | CN103830752A Preparation method and use of degradable polymer nano-microcapsules |
06/04/2014 | CN103830751A Trace gadolinium-doped manganese oxide nanoparticles for treating brain glioma |
06/04/2014 | CN103830745A Preparation and application of quantum dot-based multifunctional nano siRNA (Small Interfering Ribonucleic Acid) carrier system |
06/04/2014 | CN103830744A Sustained release gallogen-cyclodextrin compound and preparation method thereof |
06/04/2014 | CN103830743A Clathrate compound of Beta-menadione and hydrophilic Beta-cyclodextrin derivative and preparation method of clathrate compound |
06/04/2014 | CN103830742A Aspirin clathrate compound and preparation method thereof |
06/04/2014 | CN103830741A Novel compound containing tozasertib analogue structure, and preparation method and application thereof |
06/04/2014 | CN103830740A Ginsenoside Rg3 hydroxypropyl-beta-cyclodextrin inclusion compound and preparation and preparation method |
06/04/2014 | CN103830739A Medicine conveying system formed by ligand polypeptide PH1 and application thereof |
06/04/2014 | CN103830738A Lysine-grafted alginate carrier and preparation method for same |
06/04/2014 | CN103830737A Functionalized starch matrix hollow capsule |
06/04/2014 | CN103830736A Production method of starch empty capsule |
06/04/2014 | CN103830735A Gold medicinal nano-carrier with double functions of overcoming and preventing P-glycoprotein-mediated tumor multidrug resistance |
06/04/2014 | CN103830734A Preparation method and use of silica/metal composite material |
06/04/2014 | CN103830720A Medicine composition containing oxytocin |
06/04/2014 | CN103830352A Cortex moutan total glycoside soft capsules and preparation method and application thereof |
06/04/2014 | CN103830322A Soft capsule containing salvia miltiorrhiza extract and preparation method thereof |
06/04/2014 | CN103830304A Angelica sinensis volatile oil soft capsule, and preparation method thereof |
06/04/2014 | CN103830284A Ginkgo leaf total flavone dropping pills and preparation method thereof |
06/04/2014 | CN103830247A Medicinal composition for treating liver diseases |
06/04/2014 | CN103830245A Oral testosterone ester formulation and application of same in preparation of drug used for treating testosterone deficiency |
06/04/2014 | CN103830240A Fluoroquinolone medicine composition |
06/04/2014 | CN103830237A Isradipine composition medicine, capsule preparation, and preparation method and application of capsule preparation |
06/04/2014 | CN103830228A Zaltoprofen sustained-release medicinal composition, and preparation method and application thereof |
06/04/2014 | CN103830224A Water-soluble puerarin pharmaceutical composition and preparation method thereof |
06/04/2014 | CN103830219A Stable olopatadine composition |
06/04/2014 | CN103830215A Skin-disease targeted medicine adopting acetic acid and vaseline as main components |
06/04/2014 | CN103830206A Transdermal delivery preparation in three-dimensional netty spatial configuration of agomelatine and preparation method thereof |
06/04/2014 | CN103830205A Soluble thrombin nano-particle, and preparation method and application thereof |
06/04/2014 | CN103830204A Soft capsule containing silybum marianum extract and preparation method of soft capsule |
06/04/2014 | CN103830201A Dutasteride liquid soft capsules |
06/04/2014 | CN103830200A Composition of 3-n-butylphthalide derivative, and preparation method thereof |
06/04/2014 | CN103830199A Medicine preparation containing apixaban and preparation method of medicine preparation |
06/04/2014 | CN103830197A Hydrochloric acid raloxifene dispersible tablet and preparation method thereof |
06/04/2014 | CN103830196A Lasofoxifene tartrate dispersible tablet and preparation method thereof |
06/04/2014 | CN103830195A Indacaterol tablet and preparation method thereof |
06/04/2014 | CN103830194A Indacaterol solid dispersion and pharmaceutical composition containing same |